Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.06.14.732165

Parallel evolution of chimeric genes in microbial evolution experiments

Abstract

Recombination can generate new or improved proteins by merging pieces of pre-existing genes into a new whole. Here, when we reanalyzed genomic data from several laboratory evolution experiments with Escherichia coli, evidence for the convergent evolution of chimeric genes became apparent. In these experiments, a pair of paralogous genes were recombined into a single hybrid copy by large genomic deletions. In one case, the excision of a cryptic e14 prophage occurred in 6 out of 8 replicates of a 22-day fluoroquinolone-resistance evolution experiment. These parallel prophage excisions recombined an icd isocitrate dehydrogenase gene with a homologous icdC C-terminal fragment pseudogene. In the other case, convergent 23 kB deletions recombined cpsG paralogs across replicate populations of the Lenski long-term evolution experiment with Escherichia coli (LTEE), generating a chimeric phosphomannomutase. Together, these results indicate that chimeric genes evolve rapidly in bacteria and are more common than previously believed, because they are easily missed by standard genomic analyses. Experiments are needed to determine whether these chimeric proteins are adaptive, are by-products of adaptive genomic deletions, or both. Data SummaryAll data used in this study are publicly available. All data, code, and results for this study are available on Zenodo (DOI: 10.5281/zenodo.20692138). Genomic data published by Mohiuddin et al. are available in the European Nucleotide Archive (Study ERP166963 with Study Accession PRJEB83321), and genomic data published by Tenaillon et al. are available from the NCBI BioProject database under accession number PRJNA294072. Impact StatementGenomic deletions can generate chimeric proteins by splicing together parts of existing genes. However, the extent to which chimeric proteins form, and the extent to which they are adaptive are not well-understood. Complex structural variants (such as chimeric protein formation) are often missed or incompletely annotated by standard genomic pipelines. Furthermore, there is an ongoing need for new methods to detect selection on complex structural variants. In this work, we report evidence of chimeric gene formation in laboratory evolution experiments with Escherichia coli. In both experiments, chimeric genes evolved in parallel across independent replicate populations, which is an unambiguous signal of positive selection (although it remains unclear whether selection is operating on the chimeric gene, the genomic deletion creating the chimeric gene, or both). The observation of chimeric gene formation in laboratory experiments indicate that chimeric genes evolve rapidly in bacteria and are more common than previously believed. Therefore, this work points to an important new direction for microbial genomics research: what is the extent of chimeric gene formation in natural bacterial populations, and what consequences might chimeric genes have for bacterial adaptation?

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Maddamsetti, R., Orman, M.. 2026-06-15. Parallel evolution of chimeric genes in microbial evolution experiments. https://doi.org/10.64898/2026.06.14.732165

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

pTRIP, a novel integration plasmid for Listeria monocytogenes

In the past decades, several tools to genetically modify the human pathogen Listeria monocytogenes were developed. Here, we constructed a new integrative plasmid system for L. monocytogenes named pTRIP, for treB insertion plasmid. pTRIP is a vector which stably integrates into the treB locus of the wild type EGD-e. This locus encodes the sole trehalose-specific EIIB and EIIC component of a phosphotransferase system. Successful integration leads to the disruption of treB and thus, to an inability of the resulting L. monocytogenes strains to grow on trehalose as sole carbon source. Due to integration through double homologous recombination, it is the first integrative system which does not require antibiotic selection pressure. To assess functionality of the pTRIP system, prfA and its native promoter region were integrated into the treB locus of a {Delta}prfA strain. Complementation was confirmed in 78% of the isolated clones, indicating successful integration of prfA into the treB locus. We further constructed derivatives of pTRIP harboring the constitutive Pp60 (pTRIP1) and the inducible Prha (pTRIP2) promoter to further expand application possibilities. Microscopic analyses confirmed the functionality of both promoter constructs and showed dose-dependent induction for Prha. pTRIP is an efficient tool for stable gene expression as well as functional studies and expands genetic modification possibilities for L. monocytogenes.

microbiology↗

A rational design strategy and validation for protease-resistant fusion-inhibitor antiviral peptides

Peptide-based fusion inhibitors are promising pharmaceuticals in the fight against enveloped viruses relying on membrane fusion for host infection. However, peptide therapeutic applications have long been hindered by their poor stability in vivo. Here, we discovered that peptide inhibitors with the wildtype sequence of the heptad repeat 2 (HR2) domain of the SARS-CoV-2 spike protein are efficiently cleaved by Transmembrane Protease, Serine 2 (TMPRSS2), a key protease involved in the SARS-CoV-2 virus-cell fusion pathway. We then identified the corresponding cleavage sites and designed three protease-resistant peptides using ranking based on deep mutational scanning and natural occurrence. The three candidates all exhibit inhibitory activity in a cell-cell fusion assay. A high-resolution cryo-EM structure of the top candidate, HR2-NHN, bound to its HR1 target reveals the molecular basis for its potent activity. The top candidate of the cell-based screening assay significantly improved efficacy relative to the wildtype peptide when administered 12 h before infection in both an authentic virus-cell infection assay and a mouse assay. More broadly, our results suggest that the design strategies for protease-resistant peptides could be applied to a broad spectrum of other enveloped viruses and pave the way for the development of safe, prophylactic antivirals that can be administered before exposure.

microbiology↗

Host soluble inositol phosphate signaling promotes coronavirus replication

Coronaviruses rely extensively on host pathways for replication, making host-directed therapies an attractive strategy for broad-spectrum antivirals with reduced risk of viral resistance. Here we identify the host soluble inositol phosphate pathway as a previously unrecognized dependency for coronavirus infection. Genetic or pharmacologic inhibition of several kinases in this pathway markedly suppresses replication of both alpha- and betacoronaviruses, while increasing pathway activity promotes viral replication. We developed UNC7844, a potent multi-target inhibitor of these kinases, which reduces coronavirus replication by more than four orders of magnitude in cultured cells and suppresses coronavirus infection in mice. Mechanistically, UNC7844 suppresses inositol (pyro)phosphates production, disrupts phosphoinositide homeostasis, and impairs late endosomal dynamics, blocking early post-entry steps required for viral genome release and replication. Together, our findings establish the soluble inositol (pyro)phosphate pathway as an important regulator of coronavirus infection and highlight its inhibition as a promising host-directed antiviral strategy.

microbiology↗